Christel R. Brinkmann
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.
Journal: The lancet. HIV
Published: October 02, 2015
Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients.
Journal: Mediators of inflammation
Published: September 23, 2015
Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat.
Journal: Journal of virology
Published: June 08, 2015
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
Journal: PLoS pathogens
Published: May 13, 2015
Activation of latent human immunodeficiency virus by the histone deacetylase inhibitor panobinostat: a pilot study to assess effects on the central nervous system.
Journal: Open forum infectious diseases
Published: January 16, 2015
Mitochondria and the lectin pathway of complement.
Journal: The Journal of biological chemistry
Published: February 05, 2013
Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.
Journal: Human vaccines & immunotherapeutics
Published: February 02, 2013
Protein-fatty acid complexes: biochemistry, biophysics and function.
Journal: The FEBS journal
Published: October 09, 2012
Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytes.
Journal: Biochimica et biophysica acta
Published: May 05, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026